Is the treat-retreat strategy a viable option for atopic dermatitis patients undergoing Janus kinase inhibitor treatment? A report on two successful cases with upadacitinib
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY（2023）
Abstract
Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
MoreTranslated text
Key words
janus kinase inhibitor treatment,atopic dermatitis patients
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined